Sajjad Ghane Ezabadi

Dr. Sajjad Ghane Ezabadi

Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Sexual Medicine
Verified
Journal Article
Open access
PDF file
KQKowsar Qaderi
Kowsar Qaderi
MYMansoureh Yazdkhasti
Mansoureh Yazdkhasti
SZSanaz Zangeneh
Sanaz Zangeneh
BBBahar Morshed Behbahani
Bahar Morshed Behbahani
MKMehri Kalhor
Mehri Kalhor
DRDara Rasoal
Dara Rasoal
Little is known about the impact of the coronavirus on sexual behavior, function, and satisfaction. The aim of the present study was to systematically review people’s sexual function and behaviors and their changes in sexual activities during the COVID-19 pandemic. Comprehensive searches in PubMed, Web of Science, and Scopus were conducted with keywords in accordance with MeSH terms: COVID-19, SARS-CoV-2, coronavirus, sexual health, sexual function, sexual dysfunctions, sexuality, sexual orientation, sexual activities, and premarital sex. Two reviewers independently assessed full-text articles according to predefined criteria: original design, English studies, and investigating either the general population or sexual minorities. Risk of bias in the studies was assessed by the Newcastle-Ottawa Scale, and data were pooled via random effects meta-analyses. We utilized the standardized mean difference to evaluate the effects of the COVID-19 pandemic on sexual activity, functioning, and satisfaction. We included 19 studies in the analysis and 11 studies in the meta-analysis, with a sample size of 12 350. To investigate sexual activity changes, a sample size of 8838 was entered into the subgroup analysis, which showed a significant decrease in both genders (5821 women, P < .033; 3017 men, P < .008). A subgroup meta-analysis showed that the sexual function of men and women during the COVID-19 pandemic significantly declined (3974 women, P < .001; 1427 men, P < .001). Sexual desire and arousal decreased in both genders, though mainly in women. In investigating sexual satisfaction changes during the COVID-19 pandemic, a meta-analysis with a sample size of 2711 showed a significant decrease (P < .001). The most indicative changes in sexual behaviors during the pandemic were the increase in masturbating and usage of sex toys. Greater COVID-19 knowledge was associated with lower masturbation, oral sex, and vaginal sex. The more protective behaviors were associated with less hugging, kissing, cuddling, genital touching, watching porn with a partner, and vaginal sex. The COVID-19 pandemic led to increased challenges and changes for individuals’ sexual behaviors. Efforts for preventive strategies should therefore be concentrated between pandemics, while ensuring that there is information available to the population during a pandemic for help in times of psychological distress or crisis.

11 April 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
ATAtena Tamimi
Atena Tamimi
FSFarzad Sheikhzadeh
Farzad Sheikhzadeh
Sajjad Ghane EzabadiSajjad Ghane Ezabadi
Sajjad Ghane Ezabadi
MIMuhammad Islampanah
Muhammad Islampanah
PPPeyman Parhiz
Peyman Parhiz
NDNiloofar Deravi
Niloofar Deravi
Laser-assisted in situ keratomileusis (LASIK) is a unique corneal stromal laser ablation method that uses an excimer laser to reach beneath corneal dome-shaped tissues. In contrast, surface ablation methods, such as photorefractive keratectomy, include removing epithelium and cutting off the Bowman’s layer and the stromal tissue of the anterior corneal surface. Dry eye disease (DED) is the most common complication after LASIK. DED is a typical multi-factor disorder of the tear function and ocular surface that occurs when the eyes fail to produce efficient or adequate volumes of tears to moisturize the eyes. DED influences quality of life and visual perception, as symptoms often interfere with daily activities such as reading, writing, or using video display monitors. Generally, DED brings about discomfort, symptoms of visual disturbance, focal or global tear film instability with possible harm to the ocular surface, the increased osmolarity of the tear film, and subacute inflammation of the ocular surface. Almost all patients develop a degree of dryness in the postoperative period. Detection of preoperative DED and committed examination and treatment in the preoperative period, and continuing treatments postoperatively lead to rapid healing, fewer complications, and improved visual outcomes. To improve patient comfort and surgical outcomes, early treatment is required. Therefore, in this study, we aim to comprehensively review studies on the management and current treatment options for post-LASIK DED.

5 February 2023 in Health Science Reports
Verified
Journal Article
Open access
NZNasibeh Zerangian
Nasibeh Zerangian
Gisou ErabiGisou Erabi
Gisou Erabi
MPMohadeseh Poudineh
Mohadeseh Poudineh
KMKosar Monajjem
Kosar Monajjem
MDMaryam Diyanati
Maryam Diyanati
NDNiloofar Deravi
Niloofar Deravi
Venous thromboembolism (VTE) is known to be a common respiratory and/or cardiovascular complication in hospitalized patients with viral infections. Numerous studies have proven human immunodeficiency virus infection to be a prothrombotic condition. An elevated VTE risk has been observed in critically ill H1N1 influenza patients. VTE risk is remarkably higher in patients infected with the Hepatitis C virus in contrast to uninfected subjects. The elevation of D‐dimer levels supported the association between Chikungunya and the Zika virus and the rise of clinical VTE risk. Varicella‐zoster virus is a risk factor for both cellulitis and the consequent invasive bacterial disease which may take part in thrombotic initiation. Eventually, hospitalized patients infected with the coronavirus disease of 2019 (COVID‐19), the cause of the ongoing worldwide pandemic, could mainly suffer from an anomalous risk of coagulation activation with enhanced venous thrombosis events and poor quality clinical course. Although the risk of VTE in nonhospitalized COVID‐19 patients is not known yet, there are a large number of guidelines and studies on thromboprophylaxis administration for COVID‐19 cases. This study aims to take a detailed look at the effect of viral diseases on VTE, the epidemiology of VTE in viral diseases, and the diagnosis and treatment of VTE.

28 May 2022 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
Sajjad Ghane EzabadiSajjad Ghane Ezabadi
Sajjad Ghane Ezabadi
MSMohammad Ali Sahraian
Mohammad Ali Sahraian
HMHossein Maroufi
Hossein Maroufi
MSMohammad Amin Shahrbaf
Mohammad Amin Shahrbaf
SESharareh Eskandarieh
Sharareh Eskandarieh

29 August 2023 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
Sajjad Ghane EzabadiSajjad Ghane Ezabadi
Sajjad Ghane Ezabadi
SASaeideh Ayoubi
Saeideh Ayoubi
MSMohammad Ali Sahraian
Mohammad Ali Sahraian
MOMohammad Amin Omrani
Mohammad Amin Omrani
SESharareh Eskandarieh
Sharareh Eskandarieh

17 September 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
MAmaryam azimzadeh
maryam azimzadeh
NMNora Möhn
Nora Möhn
Sajjad Ghane EzabadiSajjad Ghane Ezabadi
Sajjad Ghane Ezabadi
ZEZahra Moghimi Esfandabadi
Zahra Moghimi Esfandabadi
ASAlireza Soleimani
Alireza Soleimani
FKFarshad Moharrami Kasmaie
Farshad Moharrami Kasmaie
A growing body of evidence initially suggested that patients with multiple sclerosis (MS) might be more susceptible to coronavirus disease 2019 (COVID-19). Moreover, it was speculated that patients with MS treated with immunosuppressive drugs might be at risk to develop a severe diseases course after infection with the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV2). However, the recently published data have shown that MS patients do not have a higher risk for severe COVID-19. Although there is no indication that patients with MS and immunomodulatory/immunosuppressive therapy are generally at a higher risk of severe COVID-19, it is currently being emphasized that the hazards of poorly treated MS may outweigh the putative COVID-19 dangers. In this review, we discuss the challenges and considerations for MS patients in the COVID-19 pandemic.